• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Interim interleukin 6 levels correlate with progression-free survival in patients with classic Hodgkin's disease: a pilot study.

作者信息

Villanova Pamela, Mauad Vitor Augusto Queiroz, Borducchi Davimar Miranda Maciel, Giglio Auro Del

机构信息

Faculdade de Medicina do ABC (FMABC), Santo André, SP, Brazil.

Faculdade de Medicina do ABC (FMABC), Santo André, SP, Brazil.

出版信息

Hematol Transfus Cell Ther. 2020 Jan-Mar;42(1):90-92. doi: 10.1016/j.htct.2018.11.009. Epub 2019 Mar 28.

DOI:10.1016/j.htct.2018.11.009
PMID:31582341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7031105/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15dc/7031105/a747c33e382e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15dc/7031105/a747c33e382e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15dc/7031105/a747c33e382e/gr1.jpg

相似文献

1
Interim interleukin 6 levels correlate with progression-free survival in patients with classic Hodgkin's disease: a pilot study.中期白细胞介素6水平与经典型霍奇金淋巴瘤患者的无进展生存期相关：一项初步研究。
Hematol Transfus Cell Ther. 2020 Jan-Mar;42(1):90-92. doi: 10.1016/j.htct.2018.11.009. Epub 2019 Mar 28.
2
Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group.早期中期 PET 阳性的晚期霍奇金淋巴瘤患者单独接受 BEACOPP 或联合利妥昔单抗（HD18）治疗的无进展生存期：德国霍奇金研究组开展的一项开放标签、国际、随机 3 期研究。
Lancet Oncol. 2017 Apr;18(4):454-463. doi: 10.1016/S1470-2045(17)30103-1. Epub 2017 Feb 22.
3
High frequency of primary refractory disease and low progression-free survival rate of Hodgkin's lymphoma: a decade of experience in a Latin American center.霍奇金淋巴瘤的原发性难治性疾病发生率高且无进展生存率低：拉丁美洲一个中心的十年经验
Rev Bras Hematol Hemoter. 2017 Oct-Dec;39(4):325-330. doi: 10.1016/j.bjhh.2017.08.001. Epub 2017 Sep 14.
4
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.生物标志物与中期PET扫描在预测经典型霍奇金淋巴瘤治疗结局中的联合作用：一项回顾性、欧洲多中心队列研究
Lancet Haematol. 2016 Oct;3(10):e467-e479. doi: 10.1016/S2352-3026(16)30108-9.
5
Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.淋巴瘤患者血清白细胞介素6水平升高，且与晚期霍奇金病的生存率及B症状相关。
Cancer Res. 1993 May 1;53(9):2118-22.
6
Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.爱泼斯坦-巴尔病毒相关经典型霍奇金淋巴瘤的无复发生存间隔更长：一项单机构研究。
Mod Pathol. 2003 Jun;16(6):566-73. doi: 10.1097/01.MP.0000071843.09960.BF.
7
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial.本妥昔单抗维泊妥珠单抗作为自体造血干细胞移植后巩固治疗在有复发或进展风险的霍奇金淋巴瘤患者中的应用（AETHERA）：一项随机、双盲、安慰剂对照、3 期临床试验。
Lancet. 2015 May 9;385(9980):1853-62. doi: 10.1016/S0140-6736(15)60165-9. Epub 2015 Mar 19.
8
Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma.肿瘤浸润巨噬细胞在早期霍奇金淋巴瘤中的独立预后影响
Hematol Oncol. 2017 Sep;35(3):296-302. doi: 10.1002/hon.2295. Epub 2016 Apr 6.
9
Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie.
Ann Oncol. 1997;8 Suppl 1:111-4.
10
Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials.晚期霍奇金淋巴瘤的强化治疗策略（HD9和HD12）：两项随机试验的长期生存分析
Lancet Haematol. 2018 Oct;5(10):e462-e473. doi: 10.1016/S2352-3026(18)30140-6.

引用本文的文献

1
The circuitry of the tumor microenvironment in adult and pediatric Hodgkin lymphoma: cellular composition, cytokine profile, EBV, and exosomes.成人和儿童霍奇金淋巴瘤肿瘤微环境的电路：细胞组成、细胞因子谱、EBV 和外泌体。
Cancer Rep (Hoboken). 2021 Apr;4(2):e1311. doi: 10.1002/cnr2.1311. Epub 2020 Oct 26.

本文引用的文献

1
Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma.四项欧洲 PET 报告标准在霍奇金淋巴瘤多中心试验中的一致性。
Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):1824-33. doi: 10.1007/s00259-010-1490-5. Epub 2010 May 27.
2
The 2008 WHO classification of lymphomas: implications for clinical practice and translational research.2008 年世界卫生组织淋巴瘤分类：对临床实践和转化研究的影响。
Hematology Am Soc Hematol Educ Program. 2009:523-31. doi: 10.1182/asheducation-2009.1.523.
3
Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study.
早期中期2-[18F]氟-2-脱氧-D-葡萄糖正电子发射断层扫描在晚期霍奇金淋巴瘤的预后评估方面优于国际预后评分：一项意大利-丹麦联合研究报告
J Clin Oncol. 2007 Aug 20;25(24):3746-52. doi: 10.1200/JCO.2007.11.6525. Epub 2007 Jul 23.
4
Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma: a study from the Groupe d'Etude des Lymphomes de l'Adulte.血浆细胞因子和可溶性受体特征可预测经典型霍奇金淋巴瘤患者的预后：来自成人淋巴瘤研究组的一项研究
J Clin Oncol. 2007 May 1;25(13):1732-40. doi: 10.1200/JCO.2006.08.1331. Epub 2007 Mar 26.
5
Part I: Hodgkin's lymphoma--molecular biology of Hodgkin and Reed-Sternberg cells.第一部分：霍奇金淋巴瘤——霍奇金和里德-斯腾伯格细胞的分子生物学
Lancet Oncol. 2004 Jan;5(1):11-8. doi: 10.1016/s1470-2045(03)01319-6.
6
Soluble cytokine levels correlate with the activity and clinical stage of Hodgkin's disease at diagnosis.
Leuk Lymphoma. 2000 Apr;37(3-4):333-9. doi: 10.3109/10428190009089433.
7
Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.爱泼斯坦-巴尔病毒编码的潜伏膜蛋白1（LMP1）和CD40通过涉及肿瘤坏死因子受体相关因子的核因子κB途径介导上皮细胞中白细胞介素-6的产生。
Oncogene. 1997 Jun 19;14(24):2899-916. doi: 10.1038/sj.onc.1201258.
8
Activation of interleukin-6 gene expression through the NF-kappa B transcription factor.通过核因子-κB转录因子激活白细胞介素-6基因表达。
Mol Cell Biol. 1990 May;10(5):2327-34. doi: 10.1128/mcb.10.5.2327-2334.1990.